Home > Insider Trading > Filing (0001567619-18-003533)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1656634	Gritstone Oncology Inc.	GRTS	()	DE

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1597143	Clarus Lifesciences Iii, L.p.	1700 Owens Street Suite 500 San Francisco CA 94158	No	No	Yes	No
1620148	Clarus Ventures Iii Gp, L.p.	C/O Clarus Ventures 101 Main Street, Suite 1210 Cambridge MA 02142	No	No	No	Yes
1664942	Clarus Ventures Iii, Llc	101 Main Street Suite 1210 Cambridge MA 02142	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-09-28	333,333	$15.00	333,333	No	4	P	Direct
Common Stock	Acquisiton	2018-10-02	2,234,112	$0.00	2,567,445	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2018-10-02	1,565,216	$0.00	1,565,216	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2018-10-02	668,896	$0.00	668,896	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct

Footnotes

Clarus Ventures III GP, L.P. ("GPLP"), as the sole GP of the Reporting Person, may be deemed to beneficially own certain shares held by the Reporting Person. The GPLP disclaims beneficial ownership of all shares held by the Reporting Person in which the GPLP does not have pecuniary interest. Clarus Ventures III, LLC ("GPLLC"), as the sole GP of the GPLP, may be deemed to beneficially own certain of the shares held by the Reporting Person. The GPLLC disclaims beneficial ownership of all shares held by the Reporting Person in which it does not have pecuniary interest. Each of Nicholas Galakatos, Dennis Henner, Robert Liptak, Nicholas Simon, Scott Requadt and Kurt Wheeler, as managing directors of the GPLLC, may be deemed to beneficially own certain shares held by the Reporting Person. Each of Messrs. Galakatos, Henner, Liptak, Simon, Requadt and Wheeler disclaims beneficial ownership of all shares held of record by the Reporting Person in which he does not have pecuniary interest.
The Series A Convertible Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
The Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.